Government in the Sunshine Act Meeting Notice, 39784 [2018-17260]

Download as PDF 39784 Federal Register / Vol. 83, No. 155 / Friday, August 10, 2018 / Notices Background The Commission, pursuant to section 735(b) of the Act (19 U.S.C. 1673d(b)), instituted this investigation effective June 28, 2017, following receipt of a petition filed with the Commission and Commerce by The Timken Company, North Canton, Ohio. The Commission scheduled the final phase of the investigation following notification of a preliminary determination by Commerce that imports of tapered roller bearings from Korea were being sold at LTFV within the meaning of section 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the scheduling of the final phase of the Commission’s investigation and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of February 27, 2018 (83 FR 8504). The hearing was held in Washington, DC, on June 5, 2018, and all persons who requested the opportunity were permitted to appear in person or by counsel. The Commission made this determination pursuant to section 735(b) of the Act (19 U.S.C. 1673d(b)). It completed and filed its determination in this investigation on August 6, 2018. The views of the Commission are contained in USITC Publication 4806 (August 2018), entitled Tapered Roller Bearings from Korea: Investigation No. 731–TA–1380 (Final). By order of the Commission. Issued: August 6, 2018. Lisa Barton, Secretary to the Commission. [FR Doc. 2018–17125 Filed 8–9–18; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [USITC SE–18–036] Government in the Sunshine Act Meeting Notice United States International Trade Commission. TIME AND DATE: August 24, 2018 at 9:00 a.m. PLACE: Room 101, 500 E Street SW, Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agendas for future meetings: None. daltland on DSKBBV9HB2PROD with NOTICES AGENCY HOLDING THE MEETING: participate in the determination in this investigation. VerDate Sep<11>2014 19:03 Aug 09, 2018 Jkt 244001 2. Minutes. 3. Ratification List. 4. Vote on Inv. Nos. 731–TA–678–679 and 681–682 (Fourth Review) (Stainless Steel Bar from Brazil, India, Japan, and Spain). The Commission is currently scheduled to complete and file its determinations and views of the Commission by September 11, 2018. 5. Outstanding action jackets: None. In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. By order of the Commission. Issued: August 7, 2018. William Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2018–17260 Filed 8–8–18; 11:15 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Bharanidharan Padmanabhan, M.D., Ph.D.; Decision and Order On October 20, 2017, the Acting Assistant Administrator, Diversion Control Division, Drug Enforcement Administration (hereinafter, DEA or Government), issued an Order to Show Cause to Bharanidharan Padmanabhan, M.D., Ph.D. (hereinafter, Respondent), of Brookline, Massachusetts. Order to Show Cause (hereinafter, OSC), at 1. The Show Cause Order proposes the revocation of Respondent’s Certificate of Registration on the ground that he does ‘‘not have authority to handle controlled substances in the Commonwealth of Massachusetts, the state in which . . . [he is] registered with the DEA.’’ Id. at 1 (citing 21 U.S.C. 823(f) and 824(a)(3)). Regarding jurisdiction, the Show Cause Order alleges that Respondent holds DEA Certificate of Registration No. BP7993290 at the registered address of 30 Gardner Road #6A, Brookline, Massachusetts 02445. OSC, at 1. This registration authorizes Respondent to dispense controlled substances in schedules II through V as a practitioner. The Show Cause Order alleges that this registration expires on March 31, 2020. Id. The substantive ground for the proceeding, as alleged in the Show Cause Order, is that Respondent is ‘‘without authority to handle controlled substances in the Commonwealth of Massachusetts, the state in which . . . [he is] registered . . . with the DEA.’’ Id. at 1. Specifically, the Show Cause Order alleges that the Massachusetts ‘‘Board of PO 00000 Frm 00128 Fmt 4703 Sfmt 4703 Registration in Medicine Indefinitely Suspended . . . [Respondent’s] medical license’’ on May 11, 2017, and that this indefinite suspension ‘‘became effective on July 11, 2017 and remains in effect.’’ Id. The Show Cause Order notifies Respondent of his right to request a hearing on the allegations or to submit a written statement while waiving his right to a hearing, the procedures for electing each option, and the consequences for failing to elect either option. Id. at 2 (citing 21 CFR 1301.43). The Show Cause Order also notifies Respondent of the opportunity to submit a corrective action plan. OSC, at 2–3 (citing 21 U.S.C. 824(c)(2)(C)). By letter dated November 13, 2017, Respondent requested a hearing. Hearing Request, at 1. According to the Hearing Request, Respondent ‘‘wish[es] to show why . . . [he] should retain’’ Certificate of Registration No. BP7993290. Id. Respondent’s Hearing Request refers to the ‘‘alleged’’ action of the Massachusetts Board of Registration in Medicine (hereinafter, Massachusetts Board) ‘‘indefinitely suspending . . . [his] license’’ as ‘‘corrupt and legally void,’’ and states his ‘‘position [to be] that DEA must hold all action in abeyance till the federal courts have ruled on the unlawfulness of the racketeers’ action in May 2017.’’ Id. at 2.1 The Office of Administrative Law Judges put the matter on the docket and assigned it to Administrative Law Judge Mark M. Dowd (hereinafter, ALJ). I adopt the following statement of procedural history from the ALJ’s Order Denying The Respo[n]dent’s Request for Abeyance, Granting the Government’s Motion for Summary Disposition, and Recommended Rulings, Findings of Fact, Conclusions of Law, and Decision of the Administrative Law Judge dated January 26, 2018 (hereinafter, R.D.). On November 20, 2017, this tribunal ordered the Government to file evidence to support the allegations that the Respondent lacked state authority to handle controlled substances. On December 4, 2017, the Government filed a Motion for Summary Disposition . . . . The Government submitted evidence that the Commonwealth of Massachusetts Board of Registration in Medicine indefinitely suspended the Respondent’s medical license on May 11, 2017, in the form of the Final Decision and Order from Commonwealth of Massachusetts Board of Registration . . . . Gov’t Mot. at Ex. 2, a. The Suspension was stayed for sixty days [a period which has since expired] to allow the 1 There is no corrective action plan, or indication that Respondent submitted a corrective action plan, in the record before me. E:\FR\FM\10AUN1.SGM 10AUN1

Agencies

[Federal Register Volume 83, Number 155 (Friday, August 10, 2018)]
[Notices]
[Page 39784]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17260]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[USITC SE-18-036]


Government in the Sunshine Act Meeting Notice

AGENCY HOLDING THE MEETING: United States International Trade 
Commission.

TIME AND DATE: August 24, 2018 at 9:00 a.m.

PLACE: Room 101, 500 E Street SW, Washington, DC 20436, Telephone: 
(202) 205-2000.

STATUS: Open to the public.

MATTERS TO BE CONSIDERED: 
    1. Agendas for future meetings: None.
    2. Minutes.
    3. Ratification List.
    4. Vote on Inv. Nos. 731-TA-678-679 and 681-682 (Fourth Review) 
(Stainless Steel Bar from Brazil, India, Japan, and Spain). The 
Commission is currently scheduled to complete and file its 
determinations and views of the Commission by September 11, 2018.
    5. Outstanding action jackets: None.
    In accordance with Commission policy, subject matter listed above, 
not disposed of at the scheduled meeting, may be carried over to the 
agenda of the following meeting.

    By order of the Commission.

    Issued: August 7, 2018.
William Bishop,
Supervisory Hearings and Information Officer.
[FR Doc. 2018-17260 Filed 8-8-18; 11:15 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.